Content about Tuberculosis

February 27, 2014

In findings published in the March 1 issue of the Journal of Immunology, UCLA researchers investigating the role of nutrients in helping the immune system fight against major infections show that vitamin A may play an important role in combating tuberculosis.

LOS ANGELES — In findings published in the March 1 issue of the Journal of Immunology, UCLA researchers investigating the role of nutrients in helping the immune system fight against major infections show that vitamin A may play an important role in combating tuberculosis.

December 10, 2013

Nearly all patients taking an experimental treatment for hepatitis C developed by AbbVie were cured, the drug maker said Tuesday.

NORTH CHICAGO, Ill. — Nearly all patients taking an experimental treatment for hepatitis C developed by AbbVie were cured, the drug maker said Tuesday.

May 21, 2013

Vitamin C can kill a virulent form of tuberculosis, researchers in New York have found.

NEW YORK — Vitamin C can kill a virulent form of tuberculosis, researchers in New York have found.

The researchers, at Yeshiva University's Albert Einstein College of Medicine, determined that vitamin C was able to kill drug-resistant forms of the bacteria that causes tuberculosis in lab culture, publishing their findings in the online journal Nature Communications. They had been looking into how TB bacteria become resistant to isoniazid, a first-line drug used to treat it.

March 4, 2013

Automatic spending cuts stemming from the failure of Congress and the White House to reach a budget deal will likely harm the disease-preventing capabilities of the Centers for Disease Control and Prevention, according to a new report.

NEW YORK — Automatic spending cuts stemming from the failure of Congress and the White House to reach a budget deal will likely harm the disease-preventing capabilities of the Centers for Disease Control and Prevention, according to a new report.

GlobalData, a market research and analytics firm, said the slashing of the CDC's funding by $450 million, or 8%, due to the sequester would both hamper its ability to prevent infectious diseases through immunization, surveillance and response programs while also failing to accomplish the goal of decreasing federal spending.

January 2, 2013

The U.S. Food and Drug Administration has approved a new drug from Johnson & Johnson for patients with tuberculosis who do not respond to other treatments, the company announced.

WASHINGTON — The U.S. Food and Drug Administration has approved a new drug from Johnson & Johnson for patients with tuberculosis who do not respond to other treatments, the company announced.

Tuberculosis is an air-spread infection that usually attacks the lungs, but also affect the brain, the spine and the kidneys. The drug blocks an energy-producing enzyme the tuberculosis bacteria needs to survive and is the first drug in 40 years to attempt to cure the disease using this type of treatment.

September 20, 2012

French drug maker Sanofi announced a deal with the Global Alliance for TB Drug Development Thursday to develop drugs for tuberculosis.

NEW YORK — French drug maker Sanofi announced a deal with the Global Alliance for TB Drug Development to develop drugs for tuberculosis.

The drug maker and the TB Alliance said the deal will include discovery and development of new drug compounds for the disease, which caused almost 1.5 million deaths globally and affected nearly 9 million in 2010, according to the World Health Organization.

December 9, 2011

The Centers for Disease Control and Prevention on Thursday released new recommendations to treat latent tuberculosis infection.

ATLANTA — The Centers for Disease Control and Prevention on Thursday released new recommendations to treat latent tuberculosis infection.

The new recommendations, published in CDC’s Morbidity and Mortality Weekly Report, provide guidance on how to administer a new 12-dose regimen for TB preventive therapy that will significantly shorten and simplify the course of treatment from about nine months to 12 weeks. The recommendations are based on the results of three clinical trials, as well as expert opinion.

November 17, 2011

Drug maker Eli Lilly is donating more than $4 million to the Infectious Disease Research Institute, the company said Thursday.

SEATTLE — Drug maker Eli Lilly is donating more than $4 million to the Infectious Disease Research Institute, the company said Thursday.

The company said the funding, which brings its total donations to IDRI to more than $20 million and its total funding for anti-tuberculosis efforts to more than $170 million, will support early-phase drug discovery efforts focused on identifying new drugs for tuberculosis, including strains of the virus that have grown resistant to multiple drugs. The Lilly TB Drug Discovery Initiative was started in 2007.

August 11, 2011

The consumption of processed red meat may pose an increased risk of Type 2 diabetes, according to a new study conducted by the Harvard School of Public Health.

BOSTON — The consumption of processed red meat may pose an increased risk of Type 2 diabetes, according to a new study conducted by the Harvard School of Public Health.

May 25, 2011

Researchers from the University of Texas Health Science Center at Houston found that patients with diabetes are at higher risk of contracting tuberculosis, a deadly bacterial disease, than nondiabetics.

NEW YORK — Researchers from the University of Texas Health Science Center at Houston found that patients with diabetes are at higher risk of contracting tuberculosis, a deadly bacterial disease, than nondiabetics.

The study investigators discovered among 233 patients that were diagnosed with TB between March 2006 and March 2008 — which included 61 patients in southern Texas and 172 in northeastern Mexico — 25% of TB cases were attributed to the presence of diabetes, while 6% of TB cases were caused by HIV.

October 3, 2010

The Food and Drug Administration has awarded almost $3 million for tuberculosis research, the agency...

September 8, 2010

Johnson & Johnson is seeking to aid the health of women and children in developing...

NEW BRUNSWICK, N.J. Johnson & Johnson is seeking to aid the health of women and children in developing countries with a new initiative.

J&J's Every Mother, Every Child effort is supporting the United Nations' effort to reduce mortality in women and children by 2015. The effort includes treatments for intestinal worms, health information for pregnant women over existing mobile phones, research and development of new medicines for HIV and tuberculosis, and efforts focused on enhancing birth safety and improving health.

 

April 1, 2010

The rate of reported tuberculosis cases in the United States has decreased more than 11%...

ATLANTA The rate of reported tuberculosis cases in the United States has decreased more than 11% since 2008, making it the greatest single-year decrease since the disease surveillance commenced in 1953, according to the Centers for Disease Control and Prevention.